Benjamin Machinas Beneski

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Machinas Beneski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. SVP, Chief Technical Officer Common Stock 210,172 $363,597 $1.73 02 Feb 2026 Direct
Allogene Therapeutics, Inc. SVP, Chief Technical Officer Stock Option (Right to buy) 373,757 02 Feb 2026 Direct
Allogene Therapeutics, Inc. SVP, Chief Technical Officer Restricted Stock Unit 105,720 02 Feb 2026 Direct

Insider Reports Filed by Benjamin Machinas Beneski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 02 Feb 2026 3 -$13,060 4 SVP, Chief Technical Officer 04 Feb 2026, 17:20
ALLO Allogene Therapeutics, Inc. 17 Nov 2025 1 -$959 4 SVP, Chief Technical Officer 19 Nov 2025, 16:09
ALLO Allogene Therapeutics, Inc. 14 Mar 2025 1 -$10,839 4 SVP, Chief Technical Officer 18 Mar 2025, 17:28
ALLO Allogene Therapeutics, Inc. 01 Mar 2025 2 $0 4 SVP, Chief Technical Officer 05 Mar 2025, 16:11
ALLO Allogene Therapeutics, Inc. 01 Mar 2025 0 $0 3 SVP, Chief Technical Officer 04 Mar 2025, 21:58